+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine In Oncology"

Single Cell Analysis Market - Global Forecast 2026-2032 - Product Thumbnail Image

Single Cell Analysis Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 199 Pages
  • Global
From
Genetic Testing Market - Global Forecast 2026-2032 - Product Thumbnail Image

Genetic Testing Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 186 Pages
  • Global
From
Next-Generation Oncology Devices & Solutions Market - Global Forecast 2026-2032 - Product Thumbnail Image

Next-Generation Oncology Devices & Solutions Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 196 Pages
  • Global
From
Peptide Drug Conjugates Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Thumbnail Image

Peptide Drug Conjugates Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • May 2026
  • 185 Pages
  • Global
From
Gastric Cancer Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Thumbnail Image

Gastric Cancer Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • May 2026
  • 185 Pages
  • Global
From
Patient-Derived Xenograft Model Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Thumbnail Image

Patient-Derived Xenograft Model Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • May 2026
  • 182 Pages
  • Global
From
PARP Inhibitor Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Thumbnail Image

PARP Inhibitor Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Immuno Oncology Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Thumbnail Image

Immuno Oncology Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Non-Small Cell Lung Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Thumbnail Image

Non-Small Cell Lung Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • January 2026
  • 186 Pages
  • Global
From
Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Thumbnail Image

Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • January 2026
  • 186 Pages
  • Global
From
AI In Oncology - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

AI In Oncology - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • June 2026
  • 110 Pages
  • Global
From
Perivascular Epithelioid Cell Tumors (PEComa) - Global Strategic Business Report 2026 - Product Thumbnail Image

Perivascular Epithelioid Cell Tumors (PEComa) - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 139 Pages
  • Global
From
Solitary Fibrous Tumor Treatment - Global Strategic Business Report - Product Thumbnail Image

Solitary Fibrous Tumor Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 279 Pages
  • Global
From
Tissue-based Genomic Profiling - Global Strategic Business Report - Product Thumbnail Image

Tissue-based Genomic Profiling - Global Strategic Business Report

  • Report
  • November 2026
  • 386 Pages
  • Global
From
Sarcoma Biopsy - Global Strategic Business Report - Product Thumbnail Image

Sarcoma Biopsy - Global Strategic Business Report

  • Report
  • November 2026
  • 282 Pages
  • Global
From
Medullary Thyroid Cancer - Global Strategic Business Report - Product Thumbnail Image

Medullary Thyroid Cancer - Global Strategic Business Report

  • Report
  • November 2026
  • 281 Pages
  • Global
From
Poly ADP-Ribose Polymerase (PARP) Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Poly ADP-Ribose Polymerase (PARP) Inhibitors - Global Strategic Business Report

  • Report
  • November 2026
  • 284 Pages
  • Global
From
Cell Sorters - Global Strategic Business Report - Product Thumbnail Image

Cell Sorters - Global Strategic Business Report

  • Report
  • November 2026
  • 361 Pages
  • Global
From
Gastric Cancer - Global Strategic Business Report - Product Thumbnail Image

Gastric Cancer - Global Strategic Business Report

  • Report
  • November 2026
  • 582 Pages
  • Global
From
Hyper Personalized Medicines Market - Global Strategic Business Report - Product Thumbnail Image

Hyper Personalized Medicines Market - Global Strategic Business Report

  • Report
  • November 2026
  • 390 Pages
  • Global
From
Loading Indicator

Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient. Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more